Evidence map›Paper›PMID 26962057›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2016

Cancer Stem-Like Cells Accumulated in Nickel-Induced Malignant Transformation.

Lei Wang, Jia Fan, John Andrew Hitron, Young-Ok Son, James T F Wise, Ram Vinod Roy, Donghern Kim, Jin Dai, Poyil Pratheeshkumar, Zhuo Zhang and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. [Lung Cancer Stem-like Cells and Drug Resistance].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lei Wang*Center for Research on Environmental Disease Toxicology and Cancer Biology, and.
Jia FanToxicology and Cancer Biology, and.
John Andrew HitronToxicology and Cancer Biology, and.
Young-Ok Son*Center for Research on Environmental Disease Toxicology and Cancer Biology, and.
James T F WisePharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, Kentucky 40536.
Ram Vinod Roy*Center for Research on Environmental Disease Toxicology and Cancer Biology, and.
Donghern KimToxicology and Cancer Biology, and.
Jin DaiToxicology and Cancer Biology, and.
Poyil Pratheeshkumar*Center for Research on Environmental Disease Toxicology and Cancer Biology, and.
Zhuo ZhangToxicology and Cancer Biology, and.
Xianglin Shi*Center for Research on Environmental Disease Toxicology and Cancer Biology, and xshi5@uky.edu.
Center for Environmental Health · USUniversity of Kentucky · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
TRAINING GRANT IN MOLECULAR MECHANISMS OF TOXICITY.T32ES007266 · NIEHS · UNIVERSITY OF KENTUCKY · PI LIU, XIAOQI, MELLON, ISABEL W · 1990 to 2020
$3.7M
Oxidative stress, Cr(VI) carcinogenesis, and preventionR01ES025515 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN, ZHANG, ZHUO · 2015 to 2019
$2.9M
Apoptosis resistance and Cr(VI) carcinogenesisR01ES021771 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN, ZHANG, ZHUO · 2014 to 2018
$1.7M
Prevention of UV-induced carcinogenesis by cyanidin-3-glucosideR01ES017244 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN · 2011 to 2015
$1.7M
Cell survival and arsenic carcinogenesisR01ES020870 · NIEHS · UNIVERSITY OF KENTUCKY · PI SHI, XIANGLIN · 2012 to 2016
$1.7M
NCI NIH HHS P30 CA177558NIEHS NIH HHS R01 ES017244NIEHS NIH HHS R01 ES020870NIEHS NIH HHS R01 ES021771NIEHS NIH HHS R01 ES025515NIEHS NIH HHS T32 ES007266
6 · The paper itself

Abstract

Nickel compounds are known as human carcinogens. Chronic environmental exposure to nickel is a worldwide health concern. Although the mechanisms of nickel-induced carcinogenesis are not well understood, recent studies suggest that stem cells/cancer stem cells are likely important targets. This study examines the role of cancer stem cells in nickel-induced cell transformation. The nontransformed human bronchial epithelial cell line (Beas-2B) was chronically exposed to nickel chloride for 12 months to induce cell transformation. Nickel induced Beas-2B cell transformation, and cancer stem-like cells were enriched in nickel-transformed cell (BNiT) population. The BNiT cancer stem-like cells demonstrated enhanced self-renewal and distinctive differentiation properties. In vivo tumorigenesis studies show that BNiT cancer stem-like cells possess a high tumor-initiating capability. It was also demonstrated that superoxide dismutase 1 was involved in the accumulation of cancer stem-like cells; the regulation of superoxide dismutase 1 expression was different in transformed stem-like cells and nontransformed. Overall, the accumulation of stem-like cells and their enhanced stemness functions contribute to nickel-induced tumorigenesis. Our study provides additional insight into the mechanisms by which metals or other chemicals can induce carcinogenesis.

Indexed as

AnimalsBiomarkers, TumorBronchiCell DifferentiationCell LineCell Self RenewalCell Transformation, NeoplasticEpithelial CellsHumansLung NeoplasmsMaleMice, NudeNeoplastic Stem CellsNickelPhenotypeSuperoxide Dismutase-1Biomarkers, TumorNickelnickel chlorideSOD1 protein, humanSuperoxide Dismutase-1cancer stem cellscarcinogenesisnickelreactive oxygen species (ROS)superoxide dismutase (SOD)

Identifiers

PMID26962057
PMCPMC4880134
OpenAlexW2293787658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.